Delivery Order SPE2DB20D3505-SPE2DB25FT7F2

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN34U, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.99 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.90 firm fixed-price delivery order is for the procurement of MEDROXYPROGESTERONE 150 MG/MLML, a specialty medication, with a period of performance through November 8, 2024. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is a delivery order worth $1,845.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,785,500 milliliters of medroxyprogesterone 150 mg/mL, a prescription medication. The contract has a firm fixed price and has an ultimate completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,588.19 firm fixed-price delivery order is for the supply of 4560448467 Medroxyprogesterone 150 mg/ml, with an ultimate completion date of April 3, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.28, is for the procurement of Medroxyprogesterone 150 mg/ml. It is a firm-fixed-price contract with a completion date of December 12, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite...
This federal contract award, valued at $3,189.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188922 - MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This is a delivery order (SPE2DB24FFHT7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565520133 - MEDROXYPROGESTERONE 150 MG/ML. The contract is a firm-fixed-price delivery order with a ceiling value of $3,041.80 and an ultimate completion date of August 21, 2024. The award was made on August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, valued at $1,838.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Medroxyprogesterone 150 mg/mL, a medical product. It is a Firm Fixed Price contract with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB20D3505|SPE2DB22FT4V0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,221.50 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support...
This federal contract award is for the supply of Medroxyprogesterone 150 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,033.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a Firm Fixed Price basis. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT7F2
    Delivery Order

This federal contract award SPE2DB20D3505|SPE2DB25FT7F2 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.68 Firm Fixed Price Delivery Order contract is for 4566825941 MEDROXYPROGESTERONE 150 MG/MLML, with a completion date of January 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 4/3/25, 11:00 AM